Ideal vs. real: a systematic review on handling covariates in randomized controlled trials.


Journal

BMC medical research methodology
ISSN: 1471-2288
Titre abrégé: BMC Med Res Methodol
Pays: England
ID NLM: 100968545

Informations de publication

Date de publication:
03 07 2019
Historique:
received: 11 04 2018
accepted: 26 06 2019
entrez: 5 7 2019
pubmed: 5 7 2019
medline: 7 7 2020
Statut: epublish

Résumé

In theory, efficient design of randomized controlled trials (RCTs) involves randomization algorithms that control baseline variable imbalance efficiently, and corresponding analysis involves pre-specified adjustment for baseline covariates. This review sought to explore techniques for handling potentially influential baseline variables in both the design and analysis phase of RCTs. We searched PubMed for articles indexed "randomized controlled trial", published in the NEJM, JAMA, BMJ, or Lancet for two time periods: 2009 and 2014 (before and after updated CONSORT guidelines). Upon screening (343), 298 articles underwent full review and data abstraction. Typical articles reported on superiority (86%), multicenter (92%), two-armed (79%) trials; 81% of trials involved covariates in the allocation and 84% presented adjusted analysis results. The majority reported a stratified block method (69%) of allocation, and of the trials reporting adjusted analyses, 91% were pre-specified. Trials published in 2014 were more likely to report adjusted analyses (87% vs. 79%, p = 0.0100) and more likely to pre-specify adjustment in analyses (95% vs. 85%, p = 0.0045). Studies initiated in later years (2010 or later) were less likely to use an adaptive method of randomization (p = 0.0066; 7% of those beginning in 2010 or later vs. 31% of those starting before 2000) but more likely to report a pre-specified adjusted analysis (p = 0.0029; 97% for those initiated in 2010 or later vs. 69% of those started before 2000). While optimal reporting procedures and pre-specification of adjusted analyses for RCTs tend to be progressively more prevalent over time, we see the opposite effect on reported use of covariate-adaptive randomization methods.

Sections du résumé

BACKGROUND
In theory, efficient design of randomized controlled trials (RCTs) involves randomization algorithms that control baseline variable imbalance efficiently, and corresponding analysis involves pre-specified adjustment for baseline covariates. This review sought to explore techniques for handling potentially influential baseline variables in both the design and analysis phase of RCTs.
METHODS
We searched PubMed for articles indexed "randomized controlled trial", published in the NEJM, JAMA, BMJ, or Lancet for two time periods: 2009 and 2014 (before and after updated CONSORT guidelines). Upon screening (343), 298 articles underwent full review and data abstraction.
RESULTS
Typical articles reported on superiority (86%), multicenter (92%), two-armed (79%) trials; 81% of trials involved covariates in the allocation and 84% presented adjusted analysis results. The majority reported a stratified block method (69%) of allocation, and of the trials reporting adjusted analyses, 91% were pre-specified. Trials published in 2014 were more likely to report adjusted analyses (87% vs. 79%, p = 0.0100) and more likely to pre-specify adjustment in analyses (95% vs. 85%, p = 0.0045). Studies initiated in later years (2010 or later) were less likely to use an adaptive method of randomization (p = 0.0066; 7% of those beginning in 2010 or later vs. 31% of those starting before 2000) but more likely to report a pre-specified adjusted analysis (p = 0.0029; 97% for those initiated in 2010 or later vs. 69% of those started before 2000).
CONCLUSION
While optimal reporting procedures and pre-specification of adjusted analyses for RCTs tend to be progressively more prevalent over time, we see the opposite effect on reported use of covariate-adaptive randomization methods.

Identifiants

pubmed: 31269898
doi: 10.1186/s12874-019-0787-8
pii: 10.1186/s12874-019-0787-8
pmc: PMC6610785
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

136

Subventions

Organisme : NCATS NIH HHS
ID : TL1 TR001447
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001422
Pays : United States

Références

Stat Med. 2002 Oct 15;21(19):2917-30
pubmed: 12325108
Stat Med. 2016 Feb 28;35(5):685-94
pubmed: 26337607
Stat Methods Med Res. 2015 Apr;24(2):255-72
pubmed: 21865270
Stat Med. 2002 Oct 15;21(19):2899-908
pubmed: 12325106
Control Clin Trials. 2000 Aug;21(4):330-42
pubmed: 10913808
J Biopharm Stat. 2013;23(6):1383-402
pubmed: 24138438
Contemp Clin Trials. 2010 Mar;31(2):180-4
pubmed: 20060500
Control Clin Trials. 1998 Jun;19(3):249-56
pubmed: 9620808
Contemp Clin Trials. 2015 Nov;45(Pt A):21-5
pubmed: 26244705
Stat Med. 1994 Sep 15;13(17):1715-26
pubmed: 7997705
J Clin Epidemiol. 2004 May;57(5):454-60
pubmed: 15196615
N Engl J Med. 1952 Jul 24;247(4):113-9
pubmed: 14941297
Stat Med. 1989 Apr;8(4):467-75
pubmed: 2727470
J Clin Epidemiol. 2010 Aug;63(8):e1-37
pubmed: 20346624
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Contemp Clin Trials. 2006 Oct;27(5):420-31
pubmed: 16807130
Stat Methods Med Res. 2015 Dec;24(6):989-1002
pubmed: 22287602
Contemp Clin Trials. 2014 May;38(1):9-18
pubmed: 24607294
J Clin Epidemiol. 2010 Feb;63(2):142-53
pubmed: 19716262
Control Clin Trials. 2002 Dec;23(6):662-74
pubmed: 12505244

Auteurs

Jody D Ciolino (JD)

Department of Preventive Medicine, Biostatistics Collaboration Center, Feinberg School of Medicine, Northwestern University, 680 N Lake Shore Drive, Suite 1400, Chicago, IL, 60611-4402, USA. jody.ciolino@northwestern.edu.

Hannah L Palac (HL)

AbbVie Inc, North Chicago, IL, USA.

Amy Yang (A)

AY analytics, Chicago, IL, USA.

Mireya Vaca (M)

AbbVie Inc, North Chicago, IL, USA.

Hayley M Belli (HM)

Department of Population Health, New York University Langone Health, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH